Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Biological sample collection kits industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Application trends
2.6 End-use trends
Chapter 3 Biological Sample Collection Kits Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing number of laboratory tests
3.2.1.2 Rising usage of lab tests for precise disease diagnosis
3.2.1.3 Growing R&D activities and technological advancements in sample collection techniques
3.2.1.4 Expansion of biobanking and personalized medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of advanced kits
3.2.2.2 Complexities associated with specimen collection
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By application
3.3.3 By end use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Key market trends
3.7 Technology landscape
3.8 Future market trends
3.9 Value chain analysis
3.10 Gap Analysis
3.11 Porter's analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022
Chapter 5 Biological Sample Collection Kits Market Size and Forecast, By Product (USD Million)
5.1 Key trends, by product
5.2 Swabs
5.2.1 Nasopharyngeal (NP) swabs
5.2.2 Oropharyngeal (OP) swabs
5.2.3 Nasal swabs
5.3 Viral transport media
5.4 Blood collection kits
5.5 Other consumables
Chapter 6 Biological Sample Collection Kits Market Size and Forecast, By Application (USD Million)
6.1 Key trends, by application
6.2 Diagnostics
6.3 Research
Chapter 7 Biological Sample Collection Kits Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals and clinics
7.3 Diagnostic centers
7.4 Homecare
7.5 Others
Chapter 8 Biological Sample Collection Kits Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Switzerland
8.3.8 The Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Philippines
8.4.8 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.5.6 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Egypt
8.6.6 Turkey
Chapter 9 Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.2 QIAGEN
9.3 F. Hoffmann-La Roche Ltd
9.4 Abbott Laboratories
9.5 Becton, Dickinson and Company
9.6 Laboratory Corporation of America Holdings
9.7 Seegene Inc.
9.8 Medline Industries, Inc.
9.9 Altona Diagnostics GmbH
9.10 CTK Biotech, Inc.
9.11 Lucence Health Inc.
9.12 Hardy Diagnostics
9.13 VIRCELL S.L. (Spain)
9.14 HiMedia Laboratories
9.15 Miraclean Technology Co. Ltd
